In utero SSRI exposure: Health Canada warns of risks to neonates

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2006年 / 1093卷 / 1期

关键词：

Public Health; Adverse Effect; Hypertension; Birth Defect; Pulmonary Hypertension;

D O I：

10.2165/00128415-200610930-00003

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：3 / 3

相关论文

共 50 条

[1] IV naturopathic drugs: Health Canada warns of health risks
[J]. Reactions Weekly, 2006, 1124 (1) : 2 - 2
[2] Health Canada warns of risks of using homemade sunscreens
[J]. Reactions Weekly, 2024, 2018 (1) : 3 - 3
[3] Health Canada warns of risks with sleep aid drugs
[J]. Reactions Weekly, 2009, 1274 (1) : 3 - 3
[4] Health Canada warns of health risks with methyl-1-testosterone
[J]. Reactions Weekly, 2006, 1088 (1) : 2 - 2
[5] In Utero SSRI Exposure and Risk of Clubfoot
Henriksen, Daniel Pilsgaard
Pottegard, Anton
Jimenez-Solem, Espen
Damkier, Per
[J]. EPIDEMIOLOGY, 2015, 26 (03)
[6] In utero SSRI exposure: persistent pulmonary hypertension
[J]. Reactions Weekly, 2006, 1089 (1) : 5 - 5
[7] In Utero SSRI Exposure and Risk of Clubfoot Response
Yazdy, Mahsa M.
Mitchell, Allen A.
Louik, Carol
Werler, Martha M.
[J]. EPIDEMIOLOGY, 2015, 26 (03)
[8] Health Canada advisory regarding in utero antidepressant exposure
[J]. Reactions Weekly, 2004, 1014 (1) : 2 - 2
[9] Congenital heart defects following in utero SSRI exposure
[J]. Reactions Weekly, 2017, 1643 (1) : 6 - 6
[10] In utero SSRI exposure: increased risk of serotonergic symptoms
[J]. Reactions Weekly, 2003, 964 (1) : 4 - 4

← 1 2 3 4 5 →